David Yankelevitz, MD

A close collaborator of Dr. Henschke, Dr. David Yankelevitz has carved a distinguished career as an expert in thoracic imaging. He is credited with key advances in the early identification and characterization of lung nodules, contributing decisively to the shift towards proactive lung cancer management in individuals exposed to asbestos and other carcinogens.

Yankelevitz’s research agenda focuses on the optimization of imaging protocols to minimize false positives, maximize early detection, and personalize patient care. His commitment to refining diagnostic processes has resulted in new clinical guidelines that are now standard practice in hospitals and screening centers worldwide.

Like Henschke, Yankelevitz balances scientific innovation with public education, helping policymakers and communities understand the importance and practicalities of low-dose CT screening. His collaborative work on large-scale screening initiatives—impacting countless at-risk individuals—has informed public health messaging and influenced insurance coverage decisions in the United States and abroad.

Yankelevitz is lauded for his efforts to bridge the gap between radiological science and patient needs, serving as a communicator, educator, and advocate whose influence shapes both the research agenda and lives of patients facing asbestos-induced disease.